...NARBERTH Pa. Sept. 15 /- a href http://www.gbs-cidp.o...In addition to general sessions covering the latest developments in cu...In conjunction with Wayne State University School of Medicine the Fou...Speakers include prominent neurologists who actively treat GBS and CID...

NARBERTH, Pa., Sept. 15 /PRNewswire/ -- The GBS/CIDP Foundation International will host its eleventh international symposium on Guillain-Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in King of Prussia, PA, November 5-7, 2010. Over 400 medical professionals, current and former patients, and caregivers from all over the world are expected to attend the three-day event at the Dolce Hotel – Valley Forge.

In addition to general sessions covering the latest developments in current research, diagnosis, treatment and therapies for GBS and CIDP, there will be over twenty workshops offering important current information for attendees.

Speakers include prominent neurologists who actively treat GBS and CIDP patients and conduct vital research, leading physicians in rehabilitation medicine and physicians who themselves have had the diseases. The symposium will provide invaluable information and networking opportunities for patients, relatives and caregivers.

GBS is an inflammatory disease of the peripheral nerves and is characterized by the rapid onset of weakness and often paralysis of the legs, arms, breathing muscles and face. CIDP is a rare disease of the peripheral nerves with weakness occurring over two or more months and is characterized by gradually increasing weakness of the legs and, to a lesser extent, the arms.

The Foundation was founded in 1980 by Robert and Estelle Benson to assist GBS patients and their families. A non-profit volunteer organization, it is dedicated to supporting patients and families through its national office and over 170 chapters in more than 30 countries. In addition to education of the public and medical communities the Foundation is dedicated to funding medical research and supporting patient advocacy.

(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...

(Date:12/8/2016)... TriNetX , the health research network, ... signed a membership agreement to join the network ... cures. The TriNetX network is comprised ... globally, biopharmaceutical companies and contract research organizations (CROs) ... site selection, patient recruitment, and collaborative research across ...

(Date:12/8/2016)... , Dec. 8, 2016 Pennsylvania Physician General ... Drug and Alcohol Programs Gary Tennis ... medications, known as benzodiazepines, developed with the help ... are medications that are frequently prescribed for anxiety ... are used with opioid pain medications, benzodiazepines pose ...

(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... ... Ball at The Pierre Hotel in New York, NY, on December 3rd, to ... dignitaries and physicians attended the annual event, which raised over $1 million - ...

(Date:12/9/2016)... PA (PRWEB) , ... December 09, 2016 , ... "I ... said an inventor from Winchester, Va. "I thought that if the nebulizer had a ... treatments rather than fearing them." , He developed the patent-pending NEBY to avoid the ...

(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia Medical Institute ... The name change aligns the entire company with its existing Quality Insights ... , “We are very proud of the achievements associated with the West Virginia ...

(Date:12/8/2016)... ... 08, 2016 , ... After enjoying record-breaking attendance at its ... its 33rd Annual Issues & Research Conference, March 2-3, 2017, at the ... conference is “Persistent Challenges and New Opportunities: Using Research to Accelerate the Dialogue." ...